Before they celebrate too much the gerbils should realise that even though the shares are up by 34% today at 37.1p the bard of the Boleyn is still way ahead on is short bet. But perhaps the trading statement marks a turning point for this producer of Eroxon, a treatment for Erectile Dysfunction which most customers appear to think is useless.